Showing 1 - 8 results of 8 for search 'Joo-Young Na', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study by Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, SeungHwan Lee, Kyung‐Sang Yu, In‐Jin Jang, Sang‐Ku Yoo, Youngah Kim, Jaeseong Oh
Published 2022Connect to this object online.
Book -
6
Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects by Joo Young Na, Ki Young Huh, Kyung‐Sang Yu, Joon Young Hyon, Hye Cheong Koo, Jong Ho Lee, Ji Chang You, Jae‐Yong Chung
Published 2022Connect to this object online.
Book -
7
Correction: B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis by Jung Hee Lee, Yong Jun Kim, Hyun Woo Ryu, Seung Won Shin, Eun Ji Kim, So Hyun Shin, Joon Young Park, So Young Kim, Chung Su Hwang, Joo‑Young Na, Dong Hoon Shin, Jee Yeon Kim, Hyun Jung Lee
Published 2023Connect to this object online.
Book -
8
B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis by Jung Hee Lee, Yong Jun Kim, Hyun Woo Ryu, Seung Won Shin, Eun Ji Kim, So Hyun Shin, Joon Young Park, So Young Kim, Chung Su Hwang, Joo-Young Na, Dong Hoon Shin, Jee Yeon Kim, Hyun Jung Lee
Published 2023Connect to this object online.
Book